Urbahns K - Search Results

1

Urbahns K, Woltering M, Nikolic S, Pernerstorfer J, Bischoff H, Dittrich-Wengenroth E, Lustig K. Urbahns K, et al. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3376-9. doi: 10.1016/j.bmcl.2010.04.019. Epub 2010 Apr 13. Bioorg Med Chem Lett. 2010. PMID: 20452212

2

Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.

Urbahns K, Härter M, Albers M, Schmidt D, Stelte-Ludwig B, Brüggemeier U, Vaupel A, Keldenich J, Lustig K, Tsujishita H, Gerdes C. Urbahns K, et al. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6151-4. doi: 10.1016/j.bmcl.2007.09.039. Epub 2007 Sep 14. Bioorg Med Chem Lett. 2007. PMID: 17910915

3

4-Phenyl-4H-pyrans as IK(Ca) channel blockers.

Urbahns K, Horváth E, Stasch JP, Mauler F. Urbahns K, et al. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2637-9. doi: 10.1016/s0960-894x(03)00560-2. Bioorg Med Chem Lett. 2003. PMID: 12873483

4

Tetrahydro-naphthols as orally available TRPV1 inhibitors.

Urbahns K, Yura T, Gupta JB, Tajimi M, Fujishima H, Masuda T, Yamamoto N, Ikegami Y, Marumo M, Yasoshima K, Yoshida N, Moriwaki T, Madge D, Chan F, Mogi M. Urbahns K, et al. Bioorg Med Chem Lett. 2012 May 15;22(10):3408-11. doi: 10.1016/j.bmcl.2012.03.108. Epub 2012 Apr 6. Bioorg Med Chem Lett. 2012. PMID: 22525313

5

IKCa-channel blockers. Part 2: discovery of cyclohexadienes.

Urbahns K, Goldmann S, Krüger J, Horváth E, Schuhmacher J, Grosser R, Hinz V, Mauler F. Urbahns K, et al. Bioorg Med Chem Lett. 2005 Jan 17;15(2):401-4. doi: 10.1016/j.bmcl.2004.10.063. Bioorg Med Chem Lett. 2005. PMID: 15603962

6

Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas.

Urbahns K, Härter M, Vaupel A, Albers M, Schmidt D, Brüggemeier U, Stelte-Ludwig B, Gerdes C, Tsujishita H. Urbahns K, et al. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1071-4. doi: 10.1016/s0960-894x(03)00023-4. Bioorg Med Chem Lett. 2003. PMID: 12643914

7

Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives.

Tatsuta M, Kataoka M, Yasoshima K, Sakakibara S, Shogase Y, Shimazaki M, Yura T, Li Y, Yamamoto N, Gupta J, Urbahns K. Tatsuta M, et al. Among authors: urbahns k. Bioorg Med Chem Lett. 2005 May 2;15(9):2265-9. doi: 10.1016/j.bmcl.2005.03.030. Bioorg Med Chem Lett. 2005. PMID: 15837306

8

Biphenyls as potent vitronectin receptor antagonists.

Urbahns K, Härter M, Albers M, Schmidt D, Stelte-Ludwig B, Brüggemeier U, Vaupel A, Gerdes C. Urbahns K, et al. Bioorg Med Chem Lett. 2002 Jan 21;12(2):205-8. doi: 10.1016/s0960-894x(01)00717-x. Bioorg Med Chem Lett. 2002. PMID: 11755355

9

Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence.

Urbahns K, Yura T, Mogi M, Tajimi M, Fujishima H, Masuda T, Yoshida N, Moriwaki T, Lowinger TB, Meier H, Chan F, Madge D, Gupta JB. Urbahns K, et al. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3354-7. doi: 10.1016/j.bmcl.2011.04.013. Epub 2011 Apr 9. Bioorg Med Chem Lett. 2011. PMID: 21531136

10

Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides.

Li Y, Kataoka M, Tatsuta M, Yasoshima K, Yura T, Urbahns K, Kiba A, Yamamoto N, Gupta JB, Hashimoto K. Li Y, et al. Among authors: urbahns k. Bioorg Med Chem Lett. 2005 Feb 1;15(3):805-7. doi: 10.1016/j.bmcl.2004.10.090. Bioorg Med Chem Lett. 2005. PMID: 15664861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page